Seiji Shigekawa

Seiji Shigekawa

Auto-generated profile, based on publicly available information

Seiji Shigekawa

Department of Neurosurgery, Ehime University, Toon, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Neuropathology
Verified
Journal Article
Closed access
AIAkihiro Inoue
Akihiro Inoue
HWHideaki Watanabe
Hideaki Watanabe
TKTakuya Kondo
Takuya Kondo
EKEiji Katayama
Eiji Katayama
YMYukihiro Miyazaki
Yukihiro Miyazaki
TKTakeharu Kunieda
Takeharu Kunieda

30 September 2023 in Neurospine
Verified
Journal Article
Open access
PDF file
RKRyo Kanematsu
Ryo Kanematsu
MMMasaki Mizuno
Masaki Mizuno
TITomoo Inoue
Tomoo Inoue
TTToshiyuki Takahashi
Toshiyuki Takahashi
TEToshiki Endo
Toshiki Endo
FJfor the Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan
for the Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan
Objective: The impact of adjuvant radiotherapy on overall survival (OS) and progression-free survival (PFS) of patients with grade II spinal cord astrocytomas remains controversial. Additionally, the relationship between progression and clinical deterioration after radiotherapy has not been well investigated.Methods: This study included 53 patients with grade II intramedullary spinal cord astrocytomas treated by either subtotal, partial resection or open biopsy. Their clinical performance status was assessed immediately before operation and 1, 6, 12, 24, and 60 months after surgery by Karnofsky Performance Scale (KPS). Patients with and without adjuvant radiotherapy were compared.Results: The groups with and without radiation comprised 23 and 30 patients with a mean age of 50.3 ± 22.6 years (range, 2–88 years). The mean overall disease progression rate was 47.1% during a mean follow-up period of 48.4 ± 39.8 months (range, 2.5–144.5 months). In the radiation group, 11 patients (47.8%) presented with progressive disease, whereas 14 patients (46.7%) presented with progressive disease in the group without radiation. There were no significant differences in OS or PFS among patients with or without adjuvant radiotherapy. KPS in both groups, especially radiation group, gradually decreased after operation and deteriorated before the confirmation of disease progression.Conclusion: Adjuvant radiotherapy did not show effectiveness regarding PFS or OS in patients with grade II spinal cord astrocytoma according to classical classification based on pathohistological findings.

30 September 2023 in Neurospine
Verified
Journal Article
Open access
PDF file
JMJun Muto
Jun Muto
HMHidetoshi Murata
Hidetoshi Murata
SSSeiji Shigekawa
Seiji Shigekawa
TMTakafumi Mitsuhara
Takafumi Mitsuhara
DUDaisuke Umebayashi
Daisuke Umebayashi
FJfor the Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan
for the Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan
Objective: The characteristics, imaging features, long-term surgical outcomes, and recurrence rates of primary spinal pilocytic astrocytomas (PAs) have not been clarified owing to their rarity and limited reports. Thus, this study aimed to analyze the clinical presentation, radiological features, pathological findings, and long-term outcomes of spinal PAs.Methods: Eighteen patients with spinal PAs who were surgically treated between 2009 and 2020 at 58 institutions were included in this retrospective multicenter study. Patient data, including demographics, radiographic features, treatment modalities, and long-term outcomes, were evaluated.Results: Among the 18 consecutive patients identified, 11 were women and 7 were men; the mean age at presentation was 31 years (3–73 years). Most PAs were located eccentrically, were solid or heterogeneous in appearance (cystic and solid), and had unclear margins. Gross total resection (GTR), subtotal resection (STR), partial resection (PR), and biopsy were performed in 28%, 33%, 33%, and 5% of cases, respectively. During a follow-up period of 65 ± 49 months, 4 patients developed a recurrence; however, the recurrence-free survival did not differ significantly between the GTR and non-GTR (STR, PR, and biopsy) groups.Conclusion: Primary spinal PAs are rare and present as eccentric and intermixed cystic and solid intramedullary cervical tumors. The imaging features of spinal PAs are nonspecific, and a definitive diagnosis requires pathological support. Surgical resection with prevention of neurological deterioration can serve as the first-line treatment; however, the resection rate does not affect recurrence-free survival. Investigation of relevant molecular biomarkers is required to elucidate the regrowth risk and prognostic factors.